by Jordana Choucair | Apr 28, 2022 | Life Sciences
Moderna asked the Food and Drug Administration (FDA) to grant an emergency use authorization for its COVID-19 vaccine in children 6 months to under 6 years of age. Moderna said last month its COVID-19 vaccine for children — which consists of two 25-microgram doses —...
by Jordana Choucair | Apr 27, 2022 | Life Sciences
Pfizer and BioNTech requested Food and Drug Administration (FDA) authorization of a booster dose of its COVID-19 vaccine for children 5 through 11. The companies have said that a third vaccine dose raised Omicron-fighting antibodies by 36 times in this age group....
by Jordana Choucair | Apr 26, 2022 | Life Sciences
The Food and Drug Administration (FDA) on Monday gave its first full approval for a COVID-19 treatment for children under 12. The agency granted approval to the treatment remdesivir, also known as Veklury, made by Gilead Sciences, which has already been approved as a...
by Jordana Choucair | Apr 22, 2022 | Life Sciences
The federal government has engaged in preliminary talks to buy Japanese drugmaker Shionogi & Co.’s experimental COVID-19 antiviral pill. Shionogi’s treatment is in late-stage clinical trials and hasn’t yet been authorized, but previous studies...
by Jordana Choucair | Apr 21, 2022 | Life Sciences
Several members on a panel of advisers to the Centers for Disease Control and Prevention (CDC) suggested that most U.S. adults under 50 can hold off on a fourth booster shot until later this year. The members noted that the goal of the additional doses should be to...
by Jordana Choucair | Apr 15, 2022 | Life Sciences
The Food and Drug Administration (FDA) issued an emergency use authorization for the first COVID-19 breath test. The device, called InspectIR COVID-19 Breathalyzer, works by separating and identifying chemical mixtures to detect five compounds associated with the...
Recent Comments